Hangzhou, China

Xufeng Lin

USPTO Granted Patents = 7 

Average Co-Inventor Count = 3.2

ph-index = 1


Location History:

  • Changzhou, CN (2022)
  • Hangzhou, CN (2017 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Xufeng Lin: Innovator in Chemical Compounds

Introduction

Xufeng Lin is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of chemical compounds, holding a total of seven patents. His work focuses on innovative compounds that have practical applications in various industries.

Latest Patents

One of Xufeng Lin's latest patents is for 3,3,3′,3′-tetramethyl-1,1′-spirobiindane-7,7′-diol. This compound is represented by a specific formula and can be prepared through a series of chemical reactions. It serves as a key intermediate for creating various phosphine ligands, which are essential in the chemical industry. Another notable patent involves 7,7′-dihalo-3,3,3′,3′-tetramethyl-1,1′-spirobiindane, which is also a crucial intermediate for phosphine ligand compounds.

Career Highlights

Xufeng Lin has worked with reputable institutions, including Zhejiang University and Hangzhou Liucha Pharmaceutical Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of chemistry.

Collaborations

Throughout his career, Xufeng Lin has collaborated with notable colleagues such as Huanyu Shan and Qiaoxia Zhou. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Xufeng Lin's contributions to the field of chemical compounds demonstrate his innovative spirit and dedication to advancing industry practices. His patents reflect a commitment to creating practical solutions that have significant economic and industrial applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…